IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for …
Over the last 12 months, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $40.26M worth of IDEXX Laboratories, Inc. stock.
On average, over the past 5 years, insiders at IDEXX Laboratories, Inc. have bought $0 and sold $90.85M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 750 shares for transaction amount of $199,808 was made by Kingsley Lawrence D (director) on 2019‑08‑06.
2024-09-06 | Sale | director | 500 0.0006% | $469.37 | $234,686 | +0.41% | ||
2024-05-17 | Sale | director | 200 0.0002% | $540.80 | $108,160 | -10.94% | ||
2024-03-06 | Sale | Executive Vice President | 8,104 0.0098% | $558.44 | $4.53M | -11.38% | ||
2024-03-05 | Sale | director | 1,404 0.0017% | $562.98 | $790,427 | -11.50% | ||
2024-02-08 | Sale | SVP, Chief Revenue Officer | 8,198 0.0109% | $573.87 | $4.7M | -13.36% | ||
2024-02-07 | Sale | President and CEO | 12,000 0.0159% | $572.61 | $6.87M | -13.16% | ||
2024-02-07 | Sale | EVP, CFO and Treasurer | 23,326 0.0307% | $570.01 | $13.3M | -13.16% | ||
2023-12-07 | Sale | Executive Vice President | 11,636 0.014% | $521.79 | $6.07M | -3.37% | ||
2023-12-04 | Sale | President and CEO | 7,128 0.0085% | $513.05 | $3.66M | -1.73% | ||
2023-08-31 | Sale | President and CEO | 13,424 0.0162% | $512.01 | $6.87M | -2.65% | ||
2023-08-29 | Sale | Executive Vice President | 22,909 0.0276% | $510.56 | $11.7M | -2.48% | ||
2023-08-15 | Sale | director | 492 – | $0 | $0 | -1.93% | ||
2023-08-03 | Sale | Executive Vice President | 16,027 0.0194% | $510.00 | $8.17M | -0.74% | ||
2023-05-19 | Sale | director | 10,000 0.0121% | $491.35 | $4.91M | +3.10% | ||
2023-05-18 | Sale | director | 10,000 0.012% | $489.23 | $4.89M | +2.26% | ||
2023-05-05 | Sale | director | 2,000 0.0023% | $474.89 | $949,789 | +1.95% | ||
2023-05-05 | Sale | Executive Vice President | 1,000 0.0012% | $484.00 | $484,000 | +1.95% | ||
2023-05-04 | Sale | director | 2,187 0.0026% | $469.02 | $1.03M | +6.04% | ||
2023-02-16 | Sale | Senior Vice President | 10 <0.0001% | $515.58 | $5,156 | -4.04% | ||
2023-02-16 | Sale | director | 2,187 0.0027% | $511.68 | $1.12M | -4.04% |
MCKEON BRIAN P | EVP, CFO and Treasurer | 29718 0.0363% | $418.20 | 1 | 18 | +24.62% |
Vandebroek Sophie V. | director | 1216 0.0015% | $418.20 | 1 | 6 | +18.18% |
Claflin Bruce L. | director | 161 0.0002% | $418.20 | 2 | 4 | +4.5% |
SZOSTAK M ANNE | director | 0 0% | $418.20 | 4 | 9 | +20.21% |
AYERS JONATHAN W | director | 135547 0.1655% | $418.20 | 1 | 124 | +36.54% |
BlackRock | $4.97B | 11.15 | 9.21M | +1.69% | +$82.58M | 0.11 | |
The Vanguard Group | $4.58B | 10.26 | 8.48M | +1.17% | +$53.12M | 0.08 | |
State Street | $2.04B | 4.58 | 3.78M | +0.1% | +$1.96M | 0.08 | |
AllianceBernstein | $1.61B | 3.62 | 2.99M | +1.79% | +$28.42M | 0.57 | |
Fundsmith LLP | $1.47B | 3.29 | 2.71M | -0.52% | -$7.64M | 5.74 |